TherapeuticsMD (TXMD) Retained Earnings (2010 - 2026)

TherapeuticsMD (TXMD) has reported Retained Earnings for 17 consecutive years, with -$952.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Retained Earnings changed 0.02% year-over-year to -$952.1 million; the trailing twelve-month figure through Jun 2026 stood at -$952.1 million (changed 0.02% YoY), and the FY2025 full-year result was -$952.4 million, changed 0.06% from the prior year.
• Retained Earnings was little changed at -$952.1 million in Q2 2026 per TXMD's latest filing, from -$952.3 million in the prior quarter.
• Across five years, Retained Earnings topped out at $979.2 million in Q3 2024 and bottomed at -$1.1 billion in Q1 2022.
• Historically, Retained Earnings has averaged -$535.9 million across 5 years, with a median of -$951.8 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Retained Earnings sank 197.45% in 2023, then soared 203.82% in 2024.
• Over 5 years, Retained Earnings stood at $974.5 million in 2022, then tumbled by 197.45% to -$949.6 million in 2023, then dropped by 0.23% to -$951.8 million in 2024, then dropped by 0.06% to -$952.4 million in 2025, then grew by 0.03% to -$952.1 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered -$952.1 million, -$952.3 million, and -$952.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.